Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine

Shigellosis is an important disease in the developing world, where about 90 million people become infected with Shigella spp. each year. We previously demonstrated that the type three secretion apparatus (T3SA) proteins IpaB and IpaD are protective antigens in the mouse lethal pulmonary model. In or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martinez-Becerra, Francisco J., Chen, Xiaotong, Dickenson, Nicholas E., Choudhari, Shyamal P., Harrison, Kelly, Clements, John D., Picking, William D., Van De Verg, Lillian L., Walker, Richard I., Picking, Wendy L.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2013
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837967/
https://ncbi.nlm.nih.gov/pubmed/24060976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00859-13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares